USPSTF: Screening Kids for Lipid Disorders Still Needs More Data
For the third time in 15 years, the task force has given an “I” recommendation to screening, citing not enough research.
For the third time in 15 years, the task force has given an “I” recommendation to screening, citing not enough research.
The algorithm can identify noncoronary signals, offering insights into ventricular function and cardiac index, investigators say.
Going forward, data from these kinds of studies could increasingly be used by AI to help personalize therapy for HF patients, an editorial suggests.
Going forward, data from these kinds of studies could increasingly be used by AI to help personalize therapy for HF patients, an editorial suggests.
The study of VA patients suggests that starting a new BP drug increases the risk of falls and fractures, likely due to hypotension.
Even after the intervention ended, most people kept making progress, but now it’s time to look for an impact on outcomes.
Prevention of stroke gets highlighted by guidelines and is top-of-mind for patients, but heart failure is much more common.
Physicians have adopted a one-size-fits-all approach to direct oral anticoagulants that must be reconsidered, says Geoffrey Barnes.
Edwards Lifesciences says there are “favorable trends” in hard outcomes among patients who have completed 1-year follow-up.
Even after the intervention ended, most people kept making progress, but now it’s time to look for an impact on outcomes.
D2B times are worrisome: just a third of STEMI patients were treated within the guideline-recommended 150 minutes.